What you see here is neither a virtual firework nor has Ksilink become an expressionist. We took this beautiful picture, figuring the AI-based analysis of the pharmacological validation of one of our disease models, to wish you all the best for the coming year. In 2022 Ksilink is heading towards novel disease models, new drugs to be discovered, and novel partners entering our enterprise. We warmly thank all our partners and members for their strong support and input and are looking forward to an exciting new year!
Ksilink wishes you all the best for 2022!
